Your session is about to expire
← Back to Search
Behavioral Intervention
Self-Management Workbook for Diabetes
N/A
Waitlist Available
Led By Saria Hassan, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Not having any conditions that could interfere with the accuracy of a hemoglobin a1c result: anemia, hemoglobinopathy, end-stage renal disease, chronic liver disease
Be older than 18 years old
Must not have
Cannot speak/read English
Cannot speak/read English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre test, post test (3months)
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to create a user-friendly word game-based workbook to help patients with diabetes manage their condition. Participants will use the workbook to learn about carbohydrate management, play word games related to diabetes, and
Who is the study for?
This trial is for individuals with diabetes who are interested in learning how to manage their condition through a workbook. Participants should be willing to complete the workbook either at the clinic or at home and attend follow-up sessions.
What is being tested?
The study is testing a new word game-based workbook designed to help patients understand carbohydrate management as part of their diabetes care. The effectiveness, user-friendliness, and potential challenges of this educational tool will be evaluated.
What are the potential side effects?
Since this intervention involves educational material rather than medication, there are no direct medical side effects. However, participants may experience frustration or lack of interest if they do not find the games engaging.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I don't have anemia, liver, kidney disease, or blood disorders affecting my hemoglobin.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot speak or read English.
Select...
I cannot speak or read English.
Select...
I am not willing to come back for a follow-up in 3 months.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre test, post test (3months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre test, post test (3months)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability of Intervention Measure (AIM)
Diabetes self-efficacy score (Diabetes management self-efficacy (DMSE)
Feasibility of Intervention Measure (FIM)
+1 moreSecondary study objectives
Change in Blood Pressure
Change in Hemoglobin A1c
Change in Weight
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Study groupExperimental Treatment1 Intervention
Eligible participants will utilize the workbook for a span of 3 months
Find a Location
Who is running the clinical trial?
Emory UniversityLead Sponsor
1,704 Previous Clinical Trials
2,607,273 Total Patients Enrolled
32 Trials studying Diabetes
16,846 Patients Enrolled for Diabetes
Georgia Center for Diabetes Translation ResearchOTHER
4 Previous Clinical Trials
292 Total Patients Enrolled
2 Trials studying Diabetes
59 Patients Enrolled for Diabetes
Saria Hassan, MDPrincipal InvestigatorEmory University
Catherine Park, MDPrincipal InvestigatorEmory University